We apply our expertise in a range of research areas to produce novel medicines, which will ultimately make a difference to the lives of patients across the world.
The world is facing a growing and aging population, as well as the pressure to develop treatments for life-threatening or life-altering diseases and conditions. The Medicines Discovery Institute translates world-leading research into pharmaceutical developments helping to transform care for patients.
We bring together leading researchers in immunity, neuroscience, oncology and infectious disease. With extensive knowledge of the pharmaceutical sector and proven success in bringing new medicines successfully to clinic, our vision is to develop a new approach to the development of novel drugs for neuroscience, mental health and cancer, as well as to train and inspire the next generation of medicines discovery scientists.
Our research focuses on developing new approaches to old pharmaceutical targets to repurpose and improve clinical use, as well as investigating new approaches and targets to create new therapeutics. By partnering and collaborating with industry we aim to translate research expertise into clinical practice.
Advancements in healthcare are driven by innovation, technological advancements and by integrating research into clinical practice. To create more effective and efficient treatments we will apply our expertise to identify new molecular targets, utilise our knowledge of disease processes and foster a collaborative approach in order to turn leading biomedical research into novel drugs.